Dow Jones

39 671,04

-0,51%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
USOTC
Bristol Myers Squibb Company (PK) (BMYMP)
Bristol Myers Squibb Company (PK) (BMYMP) Actualités

BMYMP

Bristol Myers Squibb (PK) (BMYMP)

Bristol Myers Squibb Company (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:BMYMP

1 2 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
09/05/2024	22h53	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
16/02/2024	22h34	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
16/02/2024	17h36	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
13/02/2024	17h54	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
13/02/2024	14h00	Edgar (US Regulatory)	Form 424B2 - Prospectus [Rule 424(b)(2)]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
06/02/2024	01h33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
03/01/2024	23h48	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/12/2023	22h13	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
26/10/2023	18h33	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
03/08/2023	21h54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
08/06/2023	21h44	Edgar (US Regulatory)	Annual Report of Employee Stock Plans (11-k)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
07/06/2023	01h40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/05/2023	22h49	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/05/2023	01h35	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
03/05/2023	19h45	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
26/04/2023	22h39	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
23/03/2023	21h44	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
14/02/2023	22h41	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
07/02/2023	20h12	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
27/07/2022	17h03	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
05/04/2022	22h53	Edgar (US Regulatory)	Notice of Exempt Solicitation. Definitive Material. (px14a6g)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
15/02/2022	23h28	Edgar (US Regulatory)	Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
15/02/2022	15h13	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
21/01/2022	23h41	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
13/12/2021	22h32	Edgar (US Regulatory)	Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/05/2021	23h03	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/05/2021	22h56	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
26/03/2021	00h32	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
04/01/2021	15h34	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	USOTC:BMYMP	Bristol Myers Squibb Company (PK)
12/11/2020	22h22	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	USOTC:BMYMP	Bristol Myers Squibb Company (PK)